21 research outputs found
Gonadotrophin-Releasing Hormone Analogues as Therapeutic Probes in Human Growth and Development: Evidence from Children with Central Precocious Puberty
No full textImportance of Leuprolide Acetate Variable Dosing for Precocious Puberty: A Range of Acceptable Suppression
No full textPrecocious pseudopuberty due to autonomous ovarian cysts: A report of ten cases and long-term follow-up
No full text
Chronic Nonendocrine Diseases with Growth Impairment; is Growth Hormone of Therapeutic Value?
No full textHelicobacter pylori Infection in Children with Constitutional Delay of Growth and Puberty
No full textHelicobacter pylori is a gastroduodenal pathogen strongly associated with chronic gastritis and duodenal ulceration. It is thought that H, pylori infection might be one of the causes of growth retardation in children. The aim of this study was to evaluate the seroprevalence of H, pylori in children with constitutional delay of growth and puberty (CDGP). H. pylori seropositivity was studied in 24 children with CDGP (22 M, 2 F) and 32 healthy age-matched children with normal pubertal development. Mean age of the children with CDGP was 14.53 +/- 1.12 yr and all of them had been diagnosed as CBGP after physical and laboratory assessment. H, pylori IgG positivity was detected in 16 of the 24 children with CDGP (66.6%) and 12 of 32 controls (37.5%) (p <0.05), This finding is consistent with the hypothesis that H, pylori infection could be one of the environmental factors causing CDGP
Gonadotrophin-Releasing Hormone Agonist Treatment of Central Precocious Puberty: an Analysis of Growth Data in a Developmental Context
No full text
Effects of Combined Gonadotropin-Releasing Hormone Agonist and Growth Hormone Therapy on Adult Height in Precocious Puberty: A Further Contribution
No full text
